Peralta, Jelly .

HRN: 21-92-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
CEFUROXIME 1.5GM (VIAL)
11/27/2022
11/27/2022
IVTT
1.5g
On Call To OR
For Prophylaxis For Surgical Procedure
Waiting Final Action 
11/28/2022
CEFUROXIME 500MG (TAB)
11/28/2022
12/05/2022
ORAL
500mg
BID
S/P LTCS TMSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: